Branden J. Lynch

ORCID: 0009-0008-4564-8894
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Endometrial and Cervical Cancer Treatments
  • Ovarian cancer diagnosis and treatment
  • Prostate Cancer Treatment and Research
  • Cancer Genomics and Diagnostics
  • Sarcoma Diagnosis and Treatment
  • Metabolism and Genetic Disorders
  • Glycogen Storage Diseases and Myoclonus
  • Mitochondrial Function and Pathology
  • Genetics and Neurodevelopmental Disorders
  • Autoimmune Neurological Disorders and Treatments
  • Zebrafish Biomedical Research Applications
  • Rabies epidemiology and control
  • Muscle metabolism and nutrition
  • Cardiomyopathy and Myosin Studies
  • Neurological diseases and metabolism
  • Prenatal Screening and Diagnostics
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Genomics and Rare Diseases
  • RNA Research and Splicing
  • Neurogenetic and Muscular Disorders Research
  • Sleep and related disorders
  • Sleep and Wakefulness Research
  • Intracranial Aneurysms: Treatment and Complications
  • Cancer Immunotherapy and Biomarkers
  • Connective tissue disorders research

University of British Columbia
2024

University College Dublin
2022

Children's Health Ireland at Crumlin
2022

Temple Street Children's University Hospital
2007-2018

Sport Wales
2013

Washington University in St. Louis
1992

In 2011, the Irish Medicines Board received reports of onset narcolepsy following vaccination against influenza A(H1N1)pdm09 with Pandemrix. A national steering committee was convened to examine association between and pandemic vaccination. We conducted a retrospective population-based cohort study. Narcolepsy cases from 1 April 2009 31 December 2010 were identified through active case finding. history gathered medical records. Pandemic status obtained databases. Two independent experts...

10.2807/1560-7917.es2014.19.17.20789 article EN cc-by Eurosurveillance 2014-05-01

Abstract Purpose: Shallow whole-genome sequencing (sWGS) can detect copy-number (CN) aberrations. In high-grade serous ovarian cancer (HGSOC) sWGS identified CN signatures such as homologous recombination deficiency (HRD) to direct therapy. We applied with targeted p53abn endometrial cancers identify additional prognostic stratification and therapeutic opportunities. Experimental Design: panel was performed on formalin-fixed, paraffin-embedded cancers. alterations, mutational data were...

10.1158/1078-0432.ccr-23-3689 article EN cc-by-nc-nd Clinical Cancer Research 2024-03-27

Low-grade serous ovarian carcinoma (LGSC) is a rare and lethal subtype of cancer. LGSC pathologically, biologically, clinically distinct from the more common high-grade (HGSC). arises borderline tumours (SBTs). The mechanism transformation for SBTs to remains poorly understood. To better understand biology LGSC, we performed whole proteome profiling formalin-fixed, paraffin-embedded tissue blocks (n = 11), HGSC 19), 26). We identified that able distinguish between histotypes epithelial...

10.1002/path.6338 article EN The Journal of Pathology 2024-07-31

SUMMARY We describe two cases of infant botulism due to Clostridium butyricum producing botulinum type E neurotoxin (BoNT/E) and a previously unreported environmental source. The infants presented at age 11 days with poor feeding lethargy, hypotonia, dilated pupils absent reflexes. Faecal samples were positive for C. BoNT/E. recovered after treatment including immune globulin intravenous (BIG-IV). BoNT/E was isolated from water tanks housing pet ‘yellow-bellied’ terrapins ( Trachemys scripta...

10.1017/s0950268814002672 article EN Epidemiology and Infection 2014-10-13

A uniparental disomy (UPD) screen using whole genome sequencing (WGS) data from 164 trios with rare disorders in the Irish population was performed to identify large runs of homozygosity origin that may harbour deleterious recessive variants. Three instances chromosome isodisomy (UPiD) were identified: one case maternal 1 and two cases paternal 2. We identified homozygous variants on isodisomic chromosomes probands: a novel p (Glu59ValfsTer20) variant TMCO1, (Pro222Leu) PRKRA, respectively....

10.3389/fgene.2022.945296 article EN cc-by Frontiers in Genetics 2022-09-14

Abstract Objectives To describe the spectrum of movement disorders and cerebrospinal fluid (CSF) neurotransmitter profiles in paediatric patients with POLG disease. Methods We identified children genetically confirmed disease, whom CSF analysis had been undertaken. Clinical data were collected retrospectively. levels compared to both standardised age‐related reference ranges non‐ presenting status epilepticus. Results Forty‐one disease identified. Almost 50% documented evidence a disorder,...

10.1007/s10545-018-0227-7 article EN cc-by Journal of Inherited Metabolic Disease 2018-08-30

A new lethal familial syndrome of unknown etiology is described in two male siblings who died the newborn period. Both had corneal edema and were hypotonic, requiring assisted ventilation at birth. Neuropathological findings included an immature appearance neocortical neurons, with cortical architecture similar to that normally seen infant 5 months gestational age. Axons myelin absent cerebral cerebellar white matter, also descending matter tracts brainstem spinal cord. Subacute inflammation...

10.1055/s-2008-1071337 article EN Neuropediatrics 1992-08-01

<p>Supplemental figure 3. Representative images of the FISH analysis performed on validation cohort to verify absolute copy number generated by rascal tool. In blue are nuclei stained with DAPI; Green arrows pointing centromeric probe CEP 7 (SpectrumGreen - Abbott Molecular); Red 11 (SpectrumOrange Molecular) probe.</p>

10.1158/1078-0432.25956466 preprint EN cc-by 2024-06-03

<p>Supplemental figure 4. Plot summarizing the relationship between Vancouver signature exposures per sample, copy number status and targeted panel mutations for key HRD genes.</p>

10.1158/1078-0432.25956463.v1 preprint EN cc-by 2024-06-03

<p>Supplemental figure 11. Kaplan-Meier survival analyses demonstrating no difference in PFS p53abn EC patients with endometrioid tumors compared to non-endometrioid (carcinosarcoma, clear cell, serous and other) once adjusting for FIGO stage.</p>

10.1158/1078-0432.25956475.v1 preprint EN cc-by 2024-06-03

<p>Supplemental figure 5. Plot summarizing the relationship between BriTROC signature exposures per sample, targeted panel mutations, copy number status, and various clinical correlates</p>

10.1158/1078-0432.25956460 preprint EN cc-by 2024-06-03
Coming Soon ...